Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort:: The role of amiloride sensitive sodium conductive pathways

被引:106
作者
Wonnemann, M [1 ]
Singer, A [1 ]
Müller, WE [1 ]
机构
[1] Univ Frankfurt, Dept Pharmacol, Bioctr Niederusel, D-60439 Frankfurt, Germany
关键词
hyperforin; St. John's Wort; amiloride sensitive sodium channel; Na+-H+ exchange; synaptosomal uptake inhibition;
D O I
10.1016/S0893-133X(00)00102-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Extracts of St. John's Wort are widely used for the treatment of depressive disorders. The active principles have not yet been finally elucidated. We have recently shown that hyperforin, a major active constituent of St. John's Wort, not only inhibits the neuronal uptake of serotonin, norepinephrine and dopamine, but also that of L-glutamate and GABA. No other antidepressant compound exhibits a similar broad uptake inhibiting profile. To investigate this unique kind of property, kinetic analyses were performed regarding the uptake of H-3-L-glutamate and H-3-GABA into Menten kinetics revealed a reduction of V-max (8.27 to 1.80 pmol/mg/min for H-3-L-glutamate, 2.76 to 0.77 pmol/mg/min for H-3-GABA) while K-m was nearly unchanged in both cases, suggesting non-competitive inhibition. The unselective uptake inhibition by hyperforin could be mimicked by the Na+-ionophore monensin and ny the Na+-K+-ATPase inhibitor ouabain. However, both mechanisms can be discarded for hyperforin. Several amiloride derivatives known to affect sodium conductance significantly enhance H-3-GABA and H-3-L-glutamate uptake and inhibit the uptake inhibition by hyperforin, while monensin or ouabain inhibition were not influenced. Selective concentrations of benzamil for amiloride sensitive Na+-channels and selective concentrations of 5'-ethylisopropylamiloride (EIPA) for the Na+-H+-exchangers both had an attenuating effect on the hyperforin inhibition of L-glutamate uptake, suggesting a possible role of amiloride sensitive Na+-channels and Na+-H+-exchangers in the mechanism of ation of hyperforin. (C) 2000 American College of Neuropsychopharmacology. Published by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:188 / 197
页数:10
相关论文
共 39 条
[1]   Activity profiles of two hyperforin-containing Hypericum extracts in behavioral models [J].
Bhattacharya, SK ;
Chakrabarti, A ;
Chatterjee, SS .
PHARMACOPSYCHIATRY, 1998, 31 :22-29
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   Effects of the total extract and fractions of hypericum perforatum in animal assays for antidepressant activity [J].
Butterweck, V ;
Wall, A ;
LieflanderWulf, U ;
Winterhoff, H ;
Nahrstedt, A .
PHARMACOPSYCHIATRY, 1997, 30 :117-124
[4]   Hyperforin as a possible antidepressant component of hypericum extracts [J].
Chatterjee, SS ;
Bhattacharya, SK ;
Wonnemann, M ;
Singer, A ;
Müller, WE .
LIFE SCIENCES, 1998, 63 (06) :499-510
[5]   Antidepressant activity of Hypericum perforatum and hyperforin: The neglected possibility [J].
Chatterjee, SS ;
Noldner, M ;
Koch, E ;
Erdelmeier, C .
PHARMACOPSYCHIATRY, 1998, 31 :7-15
[6]   Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG) [J].
Dimpfel, W ;
Schober, F ;
Mannel, M .
PHARMACOPSYCHIATRY, 1998, 31 :30-35
[7]   PROPERTIES OF GAMMA-AMINOBUTYRIC ACID (GABA) RECEPTOR-BINDING IN RAT-BRAIN SYNAPTIC MEMBRANE-FRACTIONS [J].
ENNA, SJ ;
SNYDER, SH .
BRAIN RESEARCH, 1975, 100 (01) :81-97
[8]   Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L. [J].
Erdelmeier, CAJ .
PHARMACOPSYCHIATRY, 1998, 31 :2-6
[9]   AMILORIDE AND ITS ANALOGS AS TOOLS TO INHIBIT NA+ TRANSPORT VIA THE NA+ CHANNEL, THE NA+/H+ ANTIPORT AND THE NA+/CA-2+ EXCHANGER [J].
FRELIN, C ;
BARBRY, P ;
VIGNE, P ;
CHASSANDE, O ;
CRAGOE, EJ ;
LAZDUNSKI, M .
BIOCHIMIE, 1988, 70 (09) :1285-1290
[10]   Efficacy of an Hypericum perforatum (St. John's Wort) extract in preventing and reverting a condition of escape deficit in rats [J].
Gambarana, C ;
Ghiglieri, O ;
Tolu, P ;
De Montis, MG ;
Giachetti, D ;
Bombardelli, E ;
Tagliamonte, A .
NEUROPSYCHOPHARMACOLOGY, 1999, 21 (02) :247-257